Nanjing Medlander Medical Technology Co Ltd
SSE:688273
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (27.5), the stock would be worth ¥25.53 (45% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 50.3 | ¥46.75 |
0%
|
| 3-Year Average | 27.5 | ¥25.53 |
-45%
|
| 5-Year Average | 27.5 | ¥25.53 |
-45%
|
| Industry Average | 33.5 | ¥31.14 |
-33%
|
| Country Average | 29.6 | ¥27.52 |
-41%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
¥4.3B
|
/ |
Jul 2025
¥92.9m
|
= |
|
|
¥4.3B
|
/ |
Dec 2025
¥137.4m
|
= |
|
|
¥4.3B
|
/ |
Dec 2026
¥166.7m
|
= |
|
|
¥4.3B
|
/ |
Dec 2027
¥203m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
N
|
Nanjing Medlander Medical Technology Co Ltd
SSE:688273
|
4.7B CNY | 50.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.5B USD | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.9B USD | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 24 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 44.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.1B USD | 21 |
Market Distribution
| Min | 0 |
| 30th Percentile | 17.1 |
| Median | 29.6 |
| 70th Percentile | 57.7 |
| Max | 43 569.3 |
Other Multiples
Nanjing Medlander Medical Technology Co Ltd
Glance View
Nanjing Medlander Medical Technology Co., Ltd. engages in the research, development, production, and sale of pelvic floor rehabilitation products. The company is headquartered in Nanjing, Jiangsu and currently employs 511 full-time employees. The company went IPO on 2022-08-11. The firm's products mainly include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, information products and others, including biostimulation feedback instruments, basin training instruments, basin biostimulation feedback instruments, vaginal electrodes, pelvic maintenance instruments and others. The firm's products are mainly used in obstetrics and gynecology, gynecology, pelvic floor rehabilitation centers, confinement centers, postpartum rehabilitation centers, mother and child centers and other professional institutions in medical institutions.
